. 2020 Aug 18;229:100–109. doi: 10.1016/j.ahj.2020.08.007

Table II.

Primary end point reduction with complete revascularization in acute coronary syndrome setting

Trial	Primary end point	HR (95% CI)
COMPARE-ACUTE¹⁵	All-cause death, MI, any revascularization, and cerebrovascular events	0.35 (0.22-0.55)
DANAMI-3-PRIMULTI¹⁴	All-cause death, MI, or ischemia-driven revascularization	0.56 (0.38-0.83)
COMPLETE¹⁷	CV death, MI, or ischemia-driven revascularization	0.51 (0.43-0.61)
CvLPRIT¹³	All-cause death, MI, HF, and ischemia-driven revascularization	0.45 (0.24-0.84)
PRAMI¹²	CV death, MI, or refractory angina	0.35 (0.21-0.58)

HF, heart failure.